메뉴 건너뛰기




Volumn 7, Issue 4, 2012, Pages 649-654

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304

Author keywords

CYFRA; Lung cancer

Indexed keywords

CARBOPLATIN; CELECOXIB; CYTOKERATIN 19 FRAGMENT; GEMCITABINE; ZILEUTON;

EID: 84863368614     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31824a8db0     Document Type: Article
Times cited : (60)

References (19)
  • 1
    • 0842343488 scopus 로고    scopus 로고
    • Comparison of Serum Growth Factors and Tumor Markers as Prognostic Factors for Survival in Non-small Cell Lung Cancer
    • Nieder C, Andratschke N, Jeremic B, Molls M. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer. Anticancer Res 2003;23(6D):5117-5123. (Pubitemid 38182134)
    • (2003) Anticancer Research , vol.23 , Issue.6 D , pp. 5117-5123
    • Nieder, C.1    Andratschke, N.2    Jeremic, B.3    Molls, M.4
  • 2
    • 33845570605 scopus 로고    scopus 로고
    • Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer
    • DOI 10.1002/cncr.22330
    • Ardizzoni A, Cafferata MA, Tiseo M, et al. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer. Cancer 2006;107:2842-2849. (Pubitemid 44937038)
    • (2006) Cancer , vol.107 , Issue.12 , pp. 2842-2849
    • Ardizzoni, A.1    Cafferata, M.A.2    Tiseo, M.3    Filiberti, R.4    Marroni, P.5    Grossi, F.6    Paganuzzi, M.7
  • 3
    • 61349152260 scopus 로고    scopus 로고
    • Comparison of cytokeratin 19 expression in tumor tissue and serum CYFRA 21-1 levels in non-small cell lung cancer
    • Kosacka M, Jankowska R. Comparison of cytokeratin 19 expression in tumor tissue and serum CYFRA 21-1 levels in non-small cell lung cancer. Pol Arch Med Wewn 2009;119:33-37.
    • (2009) Pol Arch Med Wewn , vol.119 , pp. 33-37
    • Kosacka, M.1    Jankowska, R.2
  • 6
    • 79959610405 scopus 로고    scopus 로고
    • Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC)
    • Cedrés S, Nuñez I, Longo M, et al. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC). Clin Lung Cancer 2011;12:172-179.
    • (2011) Clin Lung Cancer , vol.12 , pp. 172-179
    • Cedrés, S.1    Nuñez, I.2    Longo, M.3
  • 7
    • 0036356201 scopus 로고    scopus 로고
    • Monitoring cytokeratin fragment 19 (CYFRA 21-1) serum levels for early prediction of recurrence of adenocarcinoma and squamous cell carcinoma in the lung after surgical resection
    • DOI 10.1007/s004080000101
    • Yeh JJ, Liu FY, Hsu WH, Wang JJ, Ho ST, Kao A. Monitoring cytokeratin fragment 19 (CYFRA 21-1) serum levels for early prediction of recurrence of adenocarcinoma and squamous cell carcinoma in the lung after surgical resection. Lung 2002;180:273-279. (Pubitemid 36859598)
    • (2002) Lung , vol.180 , Issue.5 , pp. 273-279
    • Yeh, J.-J.1    Liu, F.-Y.2    Hsu, W.-H.3    Wang, J.-J.4    Ho, S.-T.5    Kao, A.6
  • 8
    • 0344440908 scopus 로고    scopus 로고
    • Increased CYFRA 21-1 and CEA Levels are Negative Predictors of Outcome in p-Stage I NSCLC
    • Muley T, Dienemann H, Ebert W. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC. Anticancer Res 2003;23(5b):4085-4093. (Pubitemid 37474902)
    • (2003) Anticancer Research , vol.23 , Issue.5 B , pp. 4085-4093
    • Muley, T.1    Dienemann, H.2    Ebert, W.3
  • 12
    • 33749577235 scopus 로고    scopus 로고
    • Early and specific prediction of the therapeutic efficacy in non-small cell lung cancer patients by nucleosomal DNA and cytokeratin-19 fragments
    • DOI 10.1196/annals.1368.033, Circulating Nucleic Acids in Plasma and Serum IV
    • Holdenrieder S, Steiber P, Von Pawel J, et al. Early and specific prediction of the therapeutic efficacy in non-small cell lung cancer patients by nucleosomal DNA and cytokeratin 19 fragments. Ann N Y Acad Sci 2006;1075:244-57. (Pubitemid 44532791)
    • (2006) Annals of the New York Academy of Sciences , vol.1075 , pp. 244-257
    • Holdenrieder, S.1    Stieber, P.2    Von Pawel, J.3    Raith, H.4    Nagel, D.5    Feldmann, K.6    Seidel, D.7
  • 13
    • 38049068376 scopus 로고    scopus 로고
    • Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: Association of marker changes after two chemotherapy cycles with different measures of clinical response and survival
    • Nisman B, Biran H, Heching N, et al. Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival. Br J Cancer 2008;98:77-79.
    • (2008) Br J Cancer , vol.98 , pp. 77-79
    • Nisman, B.1    Biran, H.2    Heching, N.3
  • 14
    • 0034914063 scopus 로고    scopus 로고
    • Evaluation of Cyfra 21-1: A potential tumor marker for non-small cell lung carcinomas
    • DOI 10.1007/s004080000047
    • Karnak D, Ulubay G, Kayacan O, Beder S, Ibis E, Oflaz G. Evaluation of Cyfra 21-1: a potential tumor marker for non-small cell lung carcinomas. Lung 2001;179:57-65. (Pubitemid 32667451)
    • (2001) Lung , vol.179 , Issue.1 , pp. 57-65
    • Karnak, D.1    Ulubay, G.2    Kayacan, O.3    Beder, S.4    Ibis, E.5    Oflaz, G.6
  • 15
    • 0036841417 scopus 로고    scopus 로고
    • Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients
    • Kulpa J, Wójcik E, Reinfuss M, Kolodziejski L. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem 2002;48:1931-1937. (Pubitemid 35222751)
    • (2002) Clinical Chemistry , vol.48 , Issue.11 , pp. 1931-1937
    • Kulpa, J.1    Wojcik, E.2    Reinfuss, M.3    Kolodziejski, L.4
  • 17
    • 27144452535 scopus 로고    scopus 로고
    • Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer
    • DOI 10.1378/chest.128.4.2298
    • Lee JH, Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Chest 2005;128:2298-2303. (Pubitemid 41507572)
    • (2005) Chest , vol.128 , Issue.4 , pp. 2298-2303
    • Lee, J.H.1    Chang, J.H.2
  • 18
    • 0043234142 scopus 로고    scopus 로고
    • Markers in non-small cell lung cancer - Clinical equivalence of two cytokeratin
    • Buccheri G, Torchio P, Ferrigno D. Markers in non-small cell lung cancer - clinical equivalence of two cytokeratin. Chest 2003;124:622-632.
    • (2003) Chest , vol.124 , pp. 622-632
    • Buccheri, G.1    Torchio, P.2    Ferrigno, D.3
  • 19
    • 55249095628 scopus 로고    scopus 로고
    • Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients
    • Hillas G, Moschos C, Dimakou K, et al. Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients. Scand J Clin Lab Invest 2008;68:542-547.
    • (2008) Scand J Clin Lab Invest , vol.68 , pp. 542-547
    • Hillas, G.1    Moschos, C.2    Dimakou, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.